170 related articles for article (PubMed ID: 22574836)
1. N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.
Zhong Y; Wu Y; Li C; Tang J; Wang X; Ren G; Carr A; Pérez R; Guo W
Oral Dis; 2012 Nov; 18(8):741-7. PubMed ID: 22574836
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas.
Pilco-Janeta D; De la Cruz Puebla M; Soriano J; Osorio M; Caballero I; Pérez AC; Savon L; Cremades N; Blanco R; Carr A
BMC Cancer; 2019 Jun; 19(1):556. PubMed ID: 31182063
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System.
Blanco R; Rengifo E; Cedeño M; Rengifo CE; Alonso DF; Carr A
ISRN Gastroenterol; 2011; 2011():645641. PubMed ID: 21991524
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity of the 14F7 Mab raised against N-Glycolyl GM3 Ganglioside in retinoblastoma tumours.
Torbidoni AV; Scursoni A; Camarero S; Segatori V; Gabri M; Alonso D; Chantada G; de Dávila MT
Acta Ophthalmol; 2015 Jun; 93(4):e294-300. PubMed ID: 25403557
[TBL] [Abstract][Full Text] [Related]
5. Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
Hernández AM; Rodríguez N; González JE; Reyes E; Rondón T; Griñán T; Macías A; Alfonso S; Vázquez AM; Pérez R
J Immunol; 2011 Mar; 186(6):3735-44. PubMed ID: 21300821
[TBL] [Abstract][Full Text] [Related]
6. Expression of fatty acid synthase (FASN) in oral nevi and melanoma.
de Andrade BA; León JE; Carlos R; Delgado-Azañero W; Mosqueda-Taylor A; Graner E; de Almeida OP
Oral Dis; 2011 Nov; 17(8):808-12. PubMed ID: 21819495
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccines: an update with special focus on ganglioside antigens.
Bitton RJ; Guthmann MD; Gabri MR; Carnero AJ; Alonso DF; Fainboim L; Gomez DE
Oncol Rep; 2002; 9(2):267-76. PubMed ID: 11836591
[TBL] [Abstract][Full Text] [Related]
8. A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.
Casadesús AV; Fernández-Marrero Y; Clavell M; Gómez JA; Hernández T; Moreno E; López-Requena A
Glycoconj J; 2013 Oct; 30(7):687-99. PubMed ID: 23547010
[TBL] [Abstract][Full Text] [Related]
9. A mouse IgG1 monoclonal antibody specific for N-glycolyl GM3 ganglioside recognized breast and melanoma tumors.
Carr A; Mullet A; Mazorra Z; Vázquez AM; Alfonso M; Mesa C; Rengifo E; Pérez R; Fernández LE
Hybridoma; 2000 Jun; 19(3):241-7. PubMed ID: 10952412
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical localization of S-100 protein and its subunits in melanotic lesions in the oral mucosa and skin.
Fujita S; Takahashi H; Tsuda N; Okabe H
J Oral Pathol Med; 1991 Oct; 20(9):429-32. PubMed ID: 1804988
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.
Blanco R; Blanco D; Quintana Y; Escobar X; Rengifo CE; Osorio M; Gutiérrez Z; Lamadrid J; Cedeño M; Frómeta M; Carr A; Rengifo E
Patholog Res Int; 2013; 2013():920972. PubMed ID: 24381785
[TBL] [Abstract][Full Text] [Related]
12. Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.
Rodríguez-Zhurbenko N; Martínez D; Blanco R; Rondón T; Griñán T; Hernández AM
Eur J Immunol; 2013 Mar; 43(3):826-37. PubMed ID: 23319307
[TBL] [Abstract][Full Text] [Related]
13. A cytotoxic humanized anti-ganglioside antibody produced in a murine cell line defective of N-glycolylated-glycoconjugates.
Fernández-Marrero Y; Roque-Navarro L; Hernández T; Dorvignit D; Molina-Pérez M; González A; Sosa K; López-Requena A; Pérez R; de Acosta CM
Immunobiology; 2011 Dec; 216(12):1239-47. PubMed ID: 21802167
[TBL] [Abstract][Full Text] [Related]
14. Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: results of a Phase Ib/IIa study.
Osorio M; Gracia E; Rodríguez E; Saurez G; Arango Mdel C; Noris E; Torriella A; Joan A; Gómez E; Anasagasti L; González JL; Melgares Mde L; Torres I; González J; Alonso D; Rengifo E; Carr A; Pérez R; Fernández LE
Cancer Biol Ther; 2008 Apr; 7(4):488-95. PubMed ID: 18285705
[TBL] [Abstract][Full Text] [Related]
15. Adhesion molecules in primary oral mucosal melanoma: study of claudins, integrins and immunoglobulins in a series of 35 cases.
Bologna SB; Nico MM; Hsieh R; Coutinho-Camillo CM; Buim ME; Fernandes JD; Sangueza M; Soares FA; Lourenço SV
Am J Dermatopathol; 2013 Jul; 35(5):541-54. PubMed ID: 23715077
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.
Blanco R; Rengifo E; Rengifo CE; Cedeño M; Frómeta M; Carr A
ISRN Dermatol; 2011; 2011():848909. PubMed ID: 22363862
[TBL] [Abstract][Full Text] [Related]
17. Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.
Scursoni AM; Galluzzo L; Camarero S; Lopez J; Lubieniecki F; Sampor C; Segatori VI; Gabri MR; Alonso DF; Chantada G; de Dávila MT
Clin Dev Immunol; 2011; 2011():245181. PubMed ID: 21941577
[TBL] [Abstract][Full Text] [Related]
18. Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines.
Gabri MR; Otero LL; Gomez DE; Alonso DF
J Exp Clin Cancer Res; 2009 Dec; 28(1):146. PubMed ID: 19951433
[TBL] [Abstract][Full Text] [Related]
19. Immunocytochemical study on internalization of anti-carbohydrate monoclonal antibodies.
Kusano A; Ohta S; Shitara K; Hanai N
Anticancer Res; 1993; 13(6A):2207-12. PubMed ID: 8297135
[TBL] [Abstract][Full Text] [Related]
20. Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.
Palomo AG; Santana RB; Pérez XE; Santana DB; Gabri MR; Monzon KL; Pérez AC
Clin Exp Metastasis; 2016 Oct; 33(7):717-25. PubMed ID: 27449755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
